|
| Target Protein-binding moiety 4 Basic information |
Product Name: | Target Protein-binding moiety 4 | Synonyms: | Target Protein-binding moiety 4;PROTAC BRD4-binding moiety 2;I-BET762 carboxylic acid;GSK525762A carboxylic acid;Molibresib carboxylic acid;4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetic acid, 6-(4-chlorophenyl)-8-methoxy-1-methyl-, (4S)-;I BET762 carboxylic acid,I-BET-762 carboxylic acid,IBET762 carboxylic acid | CAS: | 1300019-38-8 | MF: | C20H17ClN4O3 | MW: | 396.83 | EINECS: | | Product Categories: | | Mol File: | 1300019-38-8.mol | |
| Target Protein-binding moiety 4 Chemical Properties |
Boiling point | 648.3±65.0 °C(Predicted) | density | 1.44±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 7.14 mg/mL (17.99 mM) | pka | 4.12±0.10(Predicted) |
| Target Protein-binding moiety 4 Usage And Synthesis |
Description | Target Protein-binding moiety 4 is a BRD4(1) inhibitor with an IC50 of 7.9 μM. Target Protein-binding moiety 4 (compound 32) is a BRD4 (1) inhibitor with an IC50 of 7.9 μM[1]. | References | [1]. Yifei Yang, et al. Combined pharmacophore models as virtual screening protocol against BRD4(1) inhibitor. Medicinal Chemistry Research (2016), 25(4), 585-595. |
| Target Protein-binding moiety 4 Preparation Products And Raw materials |
|